Stock analysis, trade plans, and proprietary indicators by Trend Edge.
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by… Read full Trend Edge analysis →
| Current Price | $26.15 |
|---|---|
| Market Cap | $5.87B |
| Float | 210.9M |
| Shares Outstanding | 223.1M |
| P/E (Forward) | 58.82 |
| Price/Sales (TTM) | 2.48 |
| vs. Analyst Target | +1.7% to analyst PT |
| Profit Margin | -0.56% |
| Operating Margin (TTM) | -7.90% |
| Revenue (TTM) | $2.37B |
| Earnings Growth (YoY) | -17.40% |
| Dividend Rate | None |
| Analyst Target Price | $26.61 (13 analysts) |
| Year | Revenue | Net Income | Gross Profit | EBITDA |
|---|---|---|---|---|
| 2020 | $149M | -$18.1M | $109M | -$14.1M |
| 2021 | $272M | -$108M | $204M | -$111M |
| 2022 | $527M | -$65.7M | $409M | -$61.2M |
| 2023 | $872M | -$23.5M | $715M | -$19.9M |
| 2024 | $1.48B | $126M | $1.17B | $79.0M |
| 2025 | $2.35B | $128M | $1.73B | $160M |
| Quarter | Revenue | Net Income |
|---|---|---|
| Jun 2025 | $545M | $42.5M |
| Sep 2025 | $599M | $15.8M |
| Dec 2025 | $618M | $20.6M |
| Mar 2026 | $608M | -$92.1M |
| Insider Ownership | 5.4% |
|---|---|
| Institutional Ownership | 70.0% |
| Short Float | 30.0% |
| % of All Funds Holding | 5.05% |
| Number of Funds Holding | 415 |
Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.
| Timeframe | SMA | Value | Trend Context |
|---|---|---|---|
| Weekly | 10-Week SMA | $24.80 | Near-term / short-term trend |
| Weekly | 40-Week SMA | $33.62 | Medium-term trend |
| Weekly | 80-Week SMA | $37.62 | Cyclical trend (business cycle) |
| Weekly | 200-Week SMA | $21.53 | Secular trend (multi-year) |
| Monthly | 10-Month SMA | $33.24 | Near-term monthly trend |
| Monthly | 20-Month SMA | $36.26 | Medium-term monthly trend |
| Monthly | 40-Month SMA | $24.14 | Secular monthly trend |
Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.
| Price Level | Type | Volume Ratio | Age |
|---|---|---|---|
| $21.00 | support | 1.14x | 0 months ago |
| $14.60 | support | 1.50x | 1 months ago |
| $12.50 | support | 3.28x | 23 months ago |
| Timeframe | Avg Return | Median | Win Rate | Best | Worst |
|---|---|---|---|---|---|
| Gap | 2.51% | 0.45% | 55.56% | 27.06% | -22.28% |
| 1 Day | 1.14% | -0.32% | 44.44% | 31.02% | -22.32% |
| 1 Week | 2.67% | -0.30% | 48.15% | 52.82% | -24.29% |
| 2 Weeks | 2.77% | -2.25% | 40.74% | 51.32% | -33.42% |
| 1 Month | 11.03% | 3.23% | 69.23% | 78.45% | -37.79% |
Next earnings: August 10, 2026 (72 days away)
Insufficient historical data for monthly seasonality analysis (requires 7+ years of data).
| Day | Avg Return | Win Rate | Samples |
|---|---|---|---|
| Monday | 0.87% | 54.0% | 315 |
| Tuesday | 0.06% | 43.3% | 349 |
| Wednesday | 0.12% | 46.8% | 344 |
| Thursday | -0.16% | 42.1% | 337 |
| Friday | 0.01% | 47.5% | 337 |
Institutional holder breakdown coming soon.
Total institutional ownership: 70.0%
Total insider ownership: 5.4%
Founder-led management: Andrew Dudum (Co-Founder, Chairman & CEO)
| Total Filings | 67 |
|---|---|
| Net Value | -$144M |
| Net Shares Change | -1,218,718 |
| % of Float | -0.6% |
| C-Suite Filings | 65 |
| Clusters Detected | 9 |
| Name | Title | Net Value | Filings | Activity |
|---|---|---|---|---|
| Dudum Andrew | Chief Executive Officer | -$33.4M | 1 | 1 sell |
| Carroll Patrick Harrison | Chief Medical Officer | -$3.2M | 1 | 1 sell |
| Chi Michael | Chief Operating Officer | -$2.4M | 1 | N/A |
| Okupe Oluyemi | Chief Financial Officer | -$2.3M | 2 | N/A |
| WELLS DAVID B | +$1.2M | 1 | 1 buy | |
| Becklund Irene | PAO | -$445,278.82 | 2 | N/A |
| Autor Deborah M. | Chief Policy Officer | -$258,952.34 | 1 | N/A |
| Perez Garcia Andrea G | -$97,925 | 1 | 1 sell |
| Period | Filings | Insiders | Net Value | Seniority |
|---|---|---|---|---|
| 2025-06-17 – 2025-07-01 | 7 | 5 | -$26.5M | 7 C-suite |
| 2025-07-08 – 2025-07-18 | 4 | 3 | -$3.7M | 4 C-suite |
| 2025-07-23 – 2025-08-04 | 4 | 3 | -$8.5M | 4 C-suite |
| 2025-08-08 – 2025-08-20 | 5 | 4 | -$44.8M | 5 C-suite |
| 2025-09-17 – 2025-09-30 | 12 | 6 | -$38.5M | 12 C-suite |
| 2025-10-02 – 2025-10-14 | 4 | 3 | -$787,117.33 | 4 C-suite |
| 2025-10-20 – 2025-10-28 | 3 | 3 | -$11.4M | 3 C-suite |
| 2025-12-10 – 2025-12-23 | 6 | 6 | -$2.4M | 5 C-suite |
| 2026-03-18 – 2026-03-24 | 4 | 4 | -$2.9M | 4 C-suite |
| Date | Insider | Title | Net Value | Price After |
|---|---|---|---|---|
| 2026-05-26 | WELLS DAVID B | +$1.2M | Transaction at $24.23, now +7.9% | |
| 2025-08-08 | Carroll Patrick Harrison | Chief Medical Officer | -$3.2M | Transaction at $53.58, now -51.2% |
| 2026-04-20 | Okupe Oluyemi | Chief Financial Officer | -$1.4M | Transaction at $15.77, now +65.8% |
| 2026-03-18 | Chi Michael | Chief Operating Officer | -$2.4M | Transaction at $24.69, now +5.9% |
| 2025-08-11 | Dudum Andrew | Chief Executive Officer | -$33.4M | Transaction at $50.58, now -48.3% |
| 2025-12-10 | Perez Garcia Andrea G | -$97,925 | Transaction at $39.17, now -33.2% |
Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Hims Hers Health Inc (HIMS) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).
AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.
Get the full AI Consult analysis for HIMS on Trend Edge →